BioSpace News Archive

Drug Development

Precigen to Host a Virtual R&D Event on January 24th to Share Safety and Efficacy Data from the Phase 1 Dose Escalation and Expansion Cohorts of PRGN-2012 AdenoVerse™ Immunotherapy in Recurrent Respiratory Papillomatosis

Precigen, Inc. announced that the Company will host an investigator-led R&D event on January 24, 2023 at 4:30 PM ET to showcase the latest clinical advancements for the Company’s investigational, first-in-class PRGN-2012 off-the-shelf AdenoVerse™ Immunotherapy in recurrent respiratory papillomatosis.

January 4, 2023
·
4 min read
Biotech Bay

Kodiak Sciences to Present at the 41st Annual J.P. Morgan Healthcare Conference

Kodiak Sciences Inc. announced today that management will present at the 41st Annual J.P. Morgan Healthcare Conference in San Francisco, CA on Wednesday, January 11, 2023, at 9:00 a.m. Pacific Time (12:00 p.m. Eastern Time).

January 4, 2023
·
2 min read
Genetown

Bicara Therapeutics to Present at 41st Annual J.P. Morgan Healthcare Conference

Bicara Therapeutics today announced that Claire Mazumdar, Ph.D., MBA, Chief Executive Officer of Bicara Therapeutics, will present a corporate overview at the 41st Annual J.P. Morgan Healthcare Conference.

January 4, 2023
·
1 min read
Biotech Beach

EndoStim Concludes Pre-Submission Meeting with the FDA and Prepares Submission for Premarket Approval of the EndoStim System for the Treatment of Drug Refractory GERD

EndoStim recently met with the U.S. Food and Drug Administration (FDA) for a device pre-submission meeting in advance of a Premarket Approval (PMA) submission for the Company’s EndoStim System.

January 4, 2023
·
4 min read
University Hospitals Seidman Cancer Center selects RayStation

RaySearch Laboratories AB announces that University Hospitals Seidman Cancer Center/Case Western Reserve University in Cleveland, Ohio, in the USA, has placed an order in December 2022 and chosen to transition to RayStation®* as its primary treatment planning system.

January 4, 2023
·
6 min read
Biotech Bay

BridgeBio Pharma to Present at the J.P. Morgan Healthcare Conference 2023

BridgeBio Pharma, Inc., a commercial-stage biopharmaceutical company focused on genetic diseases and cancers, announced that members of its management team will present at the 41st Annual J.P. Morgan Healthcare Conference in San Francisco, CA on Monday, January 9 at 3:00 pm PT.

January 4, 2023
·
1 min read
Pharm Country

Context Therapeutics® Highlights 2023 Corporate Priorities and Pipeline Milestones

Context Therapeutics Inc. provided 2022 year-end updates and corporate guidance for 2023.

January 4, 2023
·
8 min read
Business

New Executive Leadership Team Appointed to Accelerate XOMA’s Differentiated Royalty Monetization Strategy

XOMA Corporation, the Biotech Royalty Aggregator, announced Jim Neal has retired as Chief Executive Officer and two finance and biotechnology industry veterans have joined in newly created executive leadership roles to drive the Company’s next phase of accelerated growth.

January 4, 2023
·
6 min read
Policy

Vivos Therapeutics Receives FDA 510(k) Clearance of its Flagship DNA Oral Appliance for Treatment of Obstructive Sleep Apnea

Vivos Therapeutics, Inc. announced a brand new clearance from the U.S. Food and Drug Administration for its proprietary DNA appliance.

January 4, 2023
·
7 min read
Business

BrainStorm Cell Therapeutics Announces Promotion of Dr. Stacy Lindborg to Co-Chief Executive Officer

BrainStorm Cell Therapeutics Inc., a leading developer of adult stem cell therapeutics for neurodegenerative diseases, announced the promotion of Dr. Stacy Lindborg to the role of Co-Chief Executive Officer.

January 4, 2023
·
7 min read